Absorbable Hemostats Industry Outlook 2025-2029: Market Set to Cross $31.29 Billion Milestone

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Absorbable Hemostats Market Size By 2025?
In recent times, there has been significant growth in the size of the absorbable hemostats market. The market is projected to expand from $23.59 billion in 2024 to $24.85 billion in 2025, with a compound annual growth rate (CAGR) of 5.3%. The development observed in the historic period is a result of advancements in surgical procedures, a growing number of chronic disease cases, an increase in demand for minimally invasive surgeries, enhancements in hemostatic materials, and greater concern for patient safety.

How Big Is the Absorbable Hemostats Market Size Expected to Grow by 2029?
In the coming years, the market size for absorbable hemostats is anticipated to experience robust growth, expanding to $31.29 billion in 2029 with a compound annual growth rate (CAGR) of 5.9%. Various factors contributing to this predicted growth during the forecast period comprise an increase in the elderly population, a heightened focus on personalized medicine, a surge in healthcare spending, advancement in healthcare infrastructure, and a rising frequency of trauma and emergencies. Notable trends during the forecast period are expected to be the production of multifunctional hemostatic products, incorporation of intelligent technologies for real-time tracking, increased usage of bioengineered materials, a rise in partnerships and collaborations, and enhancements in regulatory protocols.

View the full report here:
https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Which Key Market Drivers Powering Absorbable Hemostats Market Expansion and Growth?
The anticipated growth in the absorbable hemostats market can be attributed to the escalating number of surgical procedures. These procedures are medical interventions designed to diagnose, cure, or manage conditions by manually modifying organs or tissues through incisions or other techniques. This surge in surgical procedures is driven by the rising call for advanced medical treatments, the aging population, and breakthroughs in surgical technology which facilitate more intricate and minimally invasive procedures. Absorbable hemostats take vital roles in surgery by managing bleeding and facilitating clot formation, all while being gradually assimilated by the body. This decreases the necessity for further interventions and lowers the chances of complications after surgery. For example, as per the data from the British Association of Aesthetic Plastic Surgeons, a surgical institution based in the UK, there were 31,057 cosmetic procedures in 2022, a rise of 102% from the year earlier. As such, the absorbable hemostasis market is projected to expand due to the increasing number of surgical procedures.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Absorbable Hemostats Market?
Leading businesses in the absorbable hemostats sector are concentrating on the creation of innovative products, for instance, absorbable hemostatic powder, which aims to deliver quick and effective control of bleeding during operations. This type of powder is a medical innovation designed to manage bleeding by encouraging swift clotting at the injury location, which is then absorbed naturally by the body once its purpose has been served. To illustrate, Baxter International Inc., a healthcare company based in the US, introduced the PERCLOT absorbable hemostatic powder in July 2023. The unique molecular structure of PERCLOT granules allows for rapid water absorption, creating a gel-like adhesive matrix that forms a physical barrier to halt bleeding. This is achieved through fostering the aggregation of platelets, red blood cells, and clotting proteins such as thrombin and fibrinogen. This significant feature expands clinicians' capabilities to handle a wider variety of intraoperative bleeding situations. This is essential in lessening reliance on blood transfusions, reducing major complications, and ultimately, decreasing overall healthcare costs.

What Are the Emerging Segments in the Absorbable Hemostats Market?
The absorbable hemostats market covered in this report is segmented -

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types
2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications
3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats
2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products
3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats
4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder
5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18777&type=smp

Who Are the Global Leaders in the Absorbable Hemostats Market?
Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Becton, Dickinson and Company, Stryker Corporation, Baxter International Inc., CSL Behring, B. Braun Melsungen AG, Teleflex Incorporated, Samyang Holdings Corporation, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, Ferrosan Medical Devices A/S, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd.

Which are the Top Profitable Regional Markets for the Absorbable Hemostats Industry?
North America was the largest region in the absorbable hemostats market in 2024. The regions covered in the absorbable hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18777

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.